Every 1.2 seconds, someone develops a diabetic foot ulcer (DFU), and half become infected, leading to an amputation every 20 seconds. AOTI is a company on a mission to slow this ticking clock, help address health inequities, save the limbs, and extend the lives of these patients.
AOTI have developed Topical Wound Oxygen (TWO2), a unique multi-modality homecare therapy that uses a higher cyclical-pressure oxygen approach combined with non-contact compression and humidification. TWO2 has shown unprecedented clinical outcomes proven in the real world by the highest-level scientific studies.
AOTI offers a patient engagement at home approach alongside evidence-based outcomes - providing a path to address health disparities at the same time as reducing spending for one of the highest cost populations in healthcare.
30 май 2022
